Catalog Number 2000E-04 |
Device Problems
Complete Blockage (1094); Restricted Flow rate (1248)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 08/17/2021 |
Event Type
malfunction
|
Manufacturer Narrative
|
A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
|
|
Event Description
|
It was reported that the bd smartsite¿ needle-free connector would not flush with saline due to blockage/occlusion.The following information was provided by the initial reporter: "post iv cannulation nurse connected smart site to cannula, initiated flush but unable to flush with saline via smart site.".
|
|
Event Description
|
It was reported that the bd smartsite¿ needle-free connector would not flush with saline due to blockage/occlusion.The following information was provided by the initial reporter: "post iv cannulation nurse connected smart site to cannula, initiated flush but unable to flush with saline via smart site".
|
|
Manufacturer Narrative
|
The following fields were updated due to additional information: d10: device available for eval yes.D10: returned to manufacturer on: 2021-08-26.H6: investigation summary.One 2000e-04 sample was received in open packaging for investigation from lot 21046258.Further information provided by customer indicates that occlusion was identified whilst connected to bd posiflush syringe; however the connecting product in use at the time of the customer's experience was not returned to assist the investigation.A visual inspection of the returned sample did not identify any product defects or manufacturing issues which could have caused or contributed to the customer's experience.Functional testing was performed by connecting the smartsite component to a retained 50ml bd plastipak syringe from stock; no flow restrictions or occlusions were identified.The details of this feedback were forwarded to the manufacturing site for investigation.A review of the production records for lot 21046258 did not identify any in-process testing failures or quality deviations which may have resulted in a report of this nature.A definitive root cause for the customer's experience could not be determined as no occlusion or flow restriction was observed during testing of the returned smartsite.Following a small number of similar reports, bd has conducted an in-depth investigation to identify any potential contributing factors for occlusion of this nature.Capa 1998036 has been initiated.The investigation has determined that a potential contributor could be the result of an insufficient amount of fluorosilicone having been injected into the piston of the smartsite during the assembly process; fluorosilicone is used as a lubricant within the smartsite to ensure the consistent opening of the piston when the smartsite is activated, and an insufficient amount may cause a temporary occlusion.
|
|
Search Alerts/Recalls
|